NucAdvisor is proud to announce the acquisition of MEDraysintell a brand with international experts providing first-rate strategic intelligence in nuclear medicine, radiopharmaceutical, cyclotron, proton therapy and brachytherapy. MEDraysintell was created in 2013 by Paul-Emmanuel Goethals and Richard Zimmermann. The team brings together more than 50 years of expertise in the field of radiation healthcare.

NucAdvisor will now assume responsibility for the production and marketing of the MEDraysintell reports and will contribute its resources and expertise in nuclear medicine and radioisotopes production to expand the parties’ offering of consulting services in nuclear medicine and its supply chains.